Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia

    May 2013 in “ JAMA Dermatology ”
    Sara Samimi, Emily Y. Chu, John Seykora … Ellen J. Kim
    Studysummary This report details a case of extensive leukotrichia induced by dasatinib in a patient with refractory chronic myelogenous leukemia.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jamanetwork.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Tyrosine Kinase Inhibitors: A Review on Pharmacology, Metabolism, and Side Effects Current drug metabolism · 2009
    2. PDGF Isoforms Induce and Maintain Anagen Phase of Murine Hair Follicles Journal of Dermatological Science · 2006